Literature DB >> 22318450

Efficient transduction of healthy and malignant plasma cells by lentiviral vectors pseudotyped with measles virus glycoproteins.

M Schoenhals1, C Frecha, A Bruyer, A Caraux, J L Veyrune, M Jourdan, J Moreaux, F-L Cosset, E Verhoeyen, B Klein.   

Abstract

A lot of genes deregulated in malignant plasma cells (PCs) involved in multiple myeloma have been reported these last years. The expression of some of these genes is associated with poor survival. A critical step is to elucidate the biological mechanisms triggered by these gene products. Such studies are hampered by the difficulty to obtain malignant PCs and to genetically modify them. Usual lentiviral vectors (LVs) pseudotyped with vesicular stomatitis virus envelope glycoprotein poorly transduced healthy and malignant PCs. Here, we report that LVs pseudotyped with the hemagglutinin and fusion glycoproteins from the measles Edmonston strain (H/F-LVs) can efficiently and stably transduce healthy and primary malignant PCs, without modifying their main phenotypic characteristics. Both LV pseudotypes efficiently transduced human myeloma cell lines. Importantly, both healthy and malignant PCs expressed CD46 and SLAMF1/CD150 membrane proteins, which are critical receptors for binding and productive genetic modification by H/F-LVs. The ability to efficiently introduce and express a given gene into PCs opens the possibility to study in detail PC biology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22318450     DOI: 10.1038/leu.2012.36

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  5 in total

Review 1.  Novel anti-myeloma immunotherapies targeting the SLAM family of receptors.

Authors:  Sabarinath Venniyil Radhakrishnan; Neelam Bhardwaj; Tim Luetkens; Djordje Atanackovic
Journal:  Oncoimmunology       Date:  2017-03-28       Impact factor: 8.110

2.  IL-6 supports the generation of human long-lived plasma cells in combination with either APRIL or stromal cell-soluble factors.

Authors:  M Jourdan; M Cren; N Robert; K Bolloré; T Fest; C Duperray; F Guilloton; D Hose; K Tarte; B Klein
Journal:  Leukemia       Date:  2014-02-07       Impact factor: 11.528

3.  Forced KLF4 expression increases the generation of mature plasma cells and uncovers a network linked with plasma cell stage.

Authors:  Matthieu Schoenhals; Michel Jourdan; Anja Seckinger; Véronique Pantesco; Dirk Hose; Alboukadel Kassambara; Jérôme Moreaux; Bernard Klein
Journal:  Cell Cycle       Date:  2016-05-26       Impact factor: 4.534

4.  RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma.

Authors:  E Viziteu; B Klein; J Basbous; Y-L Lin; C Hirtz; C Gourzones; L Tiers; A Bruyer; L Vincent; C Grandmougin; A Seckinger; H Goldschmidt; A Constantinou; P Pasero; D Hose; J Moreaux
Journal:  Leukemia       Date:  2017-02-10       Impact factor: 11.528

5.  Non-integrating gamma-retroviral vectors as a versatile tool for transient zinc-finger nuclease delivery.

Authors:  Sylwia Bobis-Wozowicz; Melanie Galla; Jamal Alzubi; Johannes Kuehle; Christopher Baum; Axel Schambach; Toni Cathomen
Journal:  Sci Rep       Date:  2014-04-11       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.